![]() ![]() ![]() Truven Health and GoodRx make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. These products are provided 'AS IS' and 'as available' for use, without warranties of any kind, either express or implied. ![]() The use of the Truven Health products is at your sole risk. The safety of stimulant medication use in cardiovascular and arrhythmia patients. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Vyvanse was proven effective in short-term studies. Vyvanse helped treat ADHD throughout the day in children (aged 6-12). How to take Vyvanse (lisdexamfetamine dimesylate). Helped improve attention throughout the day in adults with ADHD. VYVANSE- lisdexamfetamine dimesylate tablet, chewable. VYVANSE- lisdexamfetamine dimesylate capsule. Diagnosis and management of attention-deficit/hyperactivity disorder in adults. Philosophical Transactions of the Royal Society of London. Misuse of prescription stimulants for weight loss, psychosocial variables, and eating disordered behaviors. Experience (mostly negative) with the use of sympathomimetic agents for weight loss. Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome): Stroke in adults-sudden numbness or weakness of the face, arm, or leg, trouble speaking, confusion, trouble walking, loss of balance or coordination, dizziness, severe headache, change in vision.Raynaud's-cool, numb, or painful fingers or toes that may change color from pale, to blue, to red.Mood and behavior changes- anxiety, nervousness, confusion, hallucinations, irritability, hostility, thoughts of suicide or self-harm, worsening mood, feelings of depression.Heart rhythm changes-fast or irregular heartbeat, dizziness, feeling faint or lightheaded, chest pain, trouble breathing.Allergic reactions-skin rash, itching, hives, swelling of the face, lips, tongue, or throat.programs, can be discontinued or changed at any time without notice at the discretion of Takeda Pharmaceuticals America, Inc.Side effects that you should report to your care team as soon as possible: ![]() This program, as well as all Takeda Pharmaceuticals America, Inc. VYVANSE® and the VYVANSE logo® are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc. Lundbeck A/S, trademarks are used under license by Takeda Pharmaceuticals America, Inc. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc. ROZEREM is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. and used under license by Takeda Pharmaceuticals America, Inc. Patent and Trademark Office and SoluTab is a trademark of Takeda Pharmaceuticals U.S.A., Inc. PREVACID is a trademark registered in the U.S. Limited and used under license by Takeda Pharmaceuticals America, Inc. PENTASA® is a registered trademark of Ferring B.V. NESINA, OSENI and KAZANO are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. MYDAYIS® and the MYDAYIS logo® are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc. MOTEGRITY® and the MOTEGRITY Logo® are registered trademarks of Takeda Pharmaceuticals U.S.A., Inc. LIALDA® and the LIALDA Logo® are registered trademarks of Nogra Pharma Limited and used under license by Takeda Pharmaceuticals America, Inc. INTUNIV® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.įOSRENOL® and the FOSRENOL logo® are registered trademarks of Shire International Licensing BV. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.ĭEXILANT and DEXILANT (with design) are trademarks of Takeda Pharmaceuticals U.S.A., Inc., registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.ĬARBATROL® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc.ĬOLCRYS is a trademark of Takeda Pharmaceuticals U.S.A., Inc., registered with the U.S. AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |